SE7612260L - Forfarande for framstellning av nya 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-1,4-diazepiner. - Google Patents

Forfarande for framstellning av nya 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-1,4-diazepiner.

Info

Publication number
SE7612260L
SE7612260L SE7612260A SE7612260A SE7612260L SE 7612260 L SE7612260 L SE 7612260L SE 7612260 A SE7612260 A SE 7612260A SE 7612260 A SE7612260 A SE 7612260A SE 7612260 L SE7612260 L SE 7612260L
Authority
SE
Sweden
Prior art keywords
atoms
group
hydrogen
alkyl
alkyl group
Prior art date
Application number
SE7612260A
Other languages
English (en)
Swedish (sv)
Inventor
W Von Bebenburg
N Schulmeyer
V Jakovlev
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Publication of SE7612260L publication Critical patent/SE7612260L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7612260A 1975-11-04 1976-11-03 Forfarande for framstellning av nya 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-1,4-diazepiner. SE7612260L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT837275A AT350056B (de) 1975-11-04 1975-11-04 Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen

Publications (1)

Publication Number Publication Date
SE7612260L true SE7612260L (sv) 1977-05-05

Family

ID=3604891

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7612260A SE7612260L (sv) 1975-11-04 1976-11-03 Forfarande for framstellning av nya 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-1,4-diazepiner.

Country Status (30)

Country Link
US (1) US4110455A (fi)
JP (1) JPS5831351B2 (fi)
AR (3) AR217814A1 (fi)
AT (1) AT350056B (fi)
AU (1) AU504228B2 (fi)
BE (1) BE847952A (fi)
CA (1) CA1076111A (fi)
CH (1) CH630920A5 (fi)
CS (1) CS191181B2 (fi)
DD (1) DD128178A5 (fi)
DE (1) DE2649116A1 (fi)
DK (1) DK142324B (fi)
EG (1) EG12280A (fi)
ES (2) ES452969A1 (fi)
FI (1) FI62088C (fi)
FR (1) FR2330404A1 (fi)
GB (1) GB1562800A (fi)
HU (1) HU177422B (fi)
IL (1) IL50816A (fi)
IN (1) IN144289B (fi)
MX (1) MX4284E (fi)
NL (1) NL7612187A (fi)
NO (1) NO146470C (fi)
PL (2) PL113803B1 (fi)
PT (1) PT65787B (fi)
RO (2) RO77294A (fi)
SE (1) SE7612260L (fi)
SU (2) SU667137A3 (fi)
YU (1) YU269176A (fi)
ZA (1) ZA766620B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1185601A (en) * 1981-02-27 1985-04-16 Walter Hunkeler Imidazodiazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
TW201201813A (en) * 2010-03-31 2012-01-16 Arqule Inc Substituted benzo-pyrido-triazolo-diazepine compounds
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
US9422292B2 (en) 2011-05-04 2016-08-23 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
US9328117B2 (en) 2011-06-17 2016-05-03 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
US9624244B2 (en) 2012-06-06 2017-04-18 Constellation Pharmaceuticals, Inc. Benzo [B] isoxazoloazepine bromodomain inhibitors and uses thereof
CN106687463B (zh) 2014-06-20 2019-04-09 星座制药公司 一种乙酰胺类化合物的晶型

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT327917B (de) * 1973-04-12 1976-02-25 Degussa Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen
US4039551A (en) * 1976-03-15 1977-08-02 The Upjohn Company 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines

Also Published As

Publication number Publication date
RO70245A (ro) 1981-06-30
CH630920A5 (de) 1982-07-15
PL118308B1 (en) 1981-09-30
AU504228B2 (en) 1979-10-04
DE2649116A1 (de) 1977-05-18
PT65787A (de) 1976-12-01
IL50816A0 (en) 1977-01-31
EG12280A (en) 1978-12-31
YU269176A (en) 1983-02-28
US4110455A (en) 1978-08-29
ES452969A1 (es) 1977-11-16
DK142324C (fi) 1981-03-02
NL7612187A (nl) 1977-05-06
AR216915A1 (es) 1980-02-15
RO77294A (ro) 1982-09-09
PL193439A1 (pl) 1979-07-16
DD128178A5 (de) 1977-11-02
FI62088B (fi) 1982-07-30
IL50816A (en) 1980-09-16
MX4284E (es) 1982-03-12
AU1931176A (en) 1978-05-11
PT65787B (de) 1978-05-10
NO146470B (no) 1982-06-28
IN144289B (fi) 1978-04-22
HU177422B (en) 1981-10-28
NO763739L (fi) 1977-05-05
CA1076111A (en) 1980-04-22
ATA837275A (de) 1978-10-15
PL113803B1 (en) 1981-01-31
CS191181B2 (en) 1979-06-29
FR2330404B1 (fi) 1979-07-20
NO146470C (no) 1982-10-06
FR2330404A1 (fr) 1977-06-03
ES452971A1 (es) 1978-10-16
AR216916A1 (es) 1980-02-15
AR217814A1 (es) 1980-04-30
GB1562800A (en) 1980-03-19
DK497076A (fi) 1977-05-05
BE847952A (fr) 1977-05-03
FI62088C (fi) 1982-11-10
JPS5831351B2 (ja) 1983-07-05
SU667137A3 (ru) 1979-06-05
SU676165A3 (ru) 1979-07-25
DK142324B (da) 1980-10-13
ZA766620B (en) 1977-12-28
FI763158A (fi) 1977-05-05
JPS5259194A (en) 1977-05-16
AT350056B (de) 1979-05-10

Similar Documents

Publication Publication Date Title
HUP9900006A2 (hu) Ciklikus GMP-specifikus foszfo-diészteráz inhibitor vegyületek, előállításuk és ezeket tartalmazó gyógyszerkészítmények
SE7612260L (sv) Forfarande for framstellning av nya 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-1,4-diazepiner.
ATE94065T1 (de) Diazepine enthaltende pharmazeutische zusammensetzungen mit plaettchen aktivierender faktor (paf)-antagonistischer wirkung.
ES8704925A1 (es) Un procedimiento para la preparacion de derivados de benzotiazol y benzotiofeno
NO861621L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 9-(2-fosfonylmethoxyethyl)-adenin
HUP9903560A2 (hu) Kinolin- és kinazolinszármazékok
ES8101563A1 (es) Un procedimiento para la preparacion de nuevos derivados he-terociclicos
AR248128A1 (es) Procedimiento para preparar esteres aromaticos sensibles o insensibles a oxidantes, utiles como inhibidores de la elastasa neutrofilica humana.
HUP0000762A2 (hu) 2-Amino-6-(2-szubsztituált-4-fenoxi)piridin-származékok, valamint a vegyületeket tartalmazó gyógyászati készítmények
ATE165972T1 (de) 2(5h)- in position 3-substituierte furanone als ca 2+ antagonisten und entzündungshemmende mittel
HUP9902456A2 (hu) Krománszármazékok és ezeket tartalmazó gyógyászati készítmények
DE69519385D1 (de) Chinazolinon-arzneimittel sowie deren verwendung
NO814299L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive trisubstituerte pyrimido(5,4-d)pyrimidiner
ATE52080T1 (de) Piperidinole und aryloxymethyl-pyrrolidinole mit blutdrucksenkenden, antidepressiven und antiarrhythmischen wirkungen.
AU554959B2 (en) Triazolo(4,3-a) quinazolin-5-ones
ES8205204A1 (es) Un procedimiento para la preparacion de derivados de imida- zol
ES457784A1 (es) Procedimiento para la preparacion de nuevos derivados de xantina.
ES8706690A1 (es) Un procedimiento para la preparacion de nuevos derivados de penem.
DK624989D0 (da) Hidtil ukendte forbindelser
ES8202817A1 (es) Metodo para preparar 2-(2-(4-(3-cloro-4-fluorofenil)-1-pipe-racinil)propil)-1,2,4-triazolo(4,3-a)piridin-3(2h)-ona y sussales
SE9701682D0 (sv) Compounds
PT900082E (pt) Utilizacao de piridilpiperazina e pirimidilpiperazina para o fabrico de um medicamento para o tratamento de perturbacoes de toxicomania
ES557155A0 (es) Un procedimiento para la obtencion de compuestos de 1-oxa-1-destia-cefalos-porina
ES471895A1 (es) Procedimiento para preparar derivados de benzamidina
ES8401952A1 (es) Un procedimiento para preparar nuevos derivados de 1,4-benzotiazina.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 7612260-5

Format of ref document f/p: F